https://orcid.org/0000-0003-1961-4128
Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Bruna Rocha, Letícia Aparecida de Morais, Mateus Costa Viana & Guilherme Carneiro. (2023) Promising strategies for improving oral bioavailability of poor water-soluble drugs. Expert Opinion on Drug Discovery 18:6, pages 615-627.
Read now
Read now
Jiawei Han, Meng Tong, Shukun Li, Xiangyu Yu, Ziqi Hu, Quan Zhang, Runze Xu & Jing Wang. (2021) Surfactant-free amorphous solid dispersion with high dissolution for bioavailability enhancement of hydrophobic drugs: a case of quercetin. Drug Development and Industrial Pharmacy 47:1, pages 153-162.
Read now
Read now
Articles from other publishers (46)
Ekta Pardhi, Devendra Singh Tomar, Rahul Khemchandani, Gananadhamu Samanthula, Pankaj Kumar Singh & Neelesh Kumar Mehra. (2024) Design, development and characterization of the Apremilast and Indomethacin coamorphous system. Journal of Molecular Structure 1299, pages 137045.
Crossref
Crossref
Xinyu Wang, Jin Cao, Zhouyuan Li, Renjie Xu, Yujie Guo, Feiyan Pu, Xuecheng Xiao, Hongzhi Du, Jianhua He & Shan Lu. (2024) Co-amorphous mixture of erlotinib hydrochloride and gallic acid for enhanced antitumor effects. Journal of Drug Delivery Science and Technology 91, pages 105200.
Crossref
Crossref
Dan Yuan, Yujie Guo, Feiyan Pu, Can Yang, Xuecheng Xiao, Hongzhi Du, Jianhua He & Shan Lu. (2024) Opportunities and challenges in enhancing the bioavailability and bioactivity of dietary flavonoids: A novel delivery system perspective. Food Chemistry 430, pages 137115.
Crossref
Crossref
Devesh U Kapoor, Sudarshan Singh, Pratishtha Sharma & Bhupendra G Prajapati. (2023) Amorphization of Low Soluble Drug with Amino Acids to Improve Its Therapeutic Efficacy: a State-of-Art-Review. AAPS PharmSciTech 24:8.
Crossref
Crossref
Hiroshi Ueda, Yuya Hirakawa, Tetsuya Miyano, Yuzuki Nakayama, Yuta Hatanaka, Hiromasa Uchiyama, Yuichi Tozuka & Kazunori Kadota. (2023) Improvement in Inhalation Properties of Theophylline and Levofloxacin by Co-Amorphization and Enhancement in Its Stability by Addition of Amino Acid as a Third Component. Molecular Pharmaceutics 20:12, pages 6368-6379.
Crossref
Crossref
Jirun Jia, Rui Bao, Jiayue Hou, Mengdi Qin, Wen Li, Li Yang & Qiang Fu. (2023) A rapid and sensitive ultra‐high‐performance liquid chromatography‐tandem mass spectrometry method for the simultaneous determination of atorvastatin calcium and lisinopril in rat plasma and its application in a pharmacokinetic study. SEPARATION SCIENCE PLUS 6:12.
Crossref
Crossref
Peiyi Liang, Yi Hu, Zhuxian Wang, Yinglin Guo, Hongkai Chen, CuiPing Jiang, Quanfu Zeng, Chunyan Shen, Yufan Wu, Li Liu, Yankui Yi, Hongxia Zhu, Zhijun Yang & Qiang Liu. (2023) Investigation of the preparation, characterization, and whitening activity of co-amorphous glabridin and oxymatrine. CrystEngComm 25:45, pages 6252-6265.
Crossref
Crossref
Jiawei Han, Mengyuan Tang, Yang Yang, Wen Sun, Zhimin Yue, Yunran Zhang, Yijun Zhu, Xiaoqian Liu & Jue Wang. (2023) Amorphous solid dispersions: Stability mechanism, design strategy and key production technique of hot melt extrusion. International Journal of Pharmaceutics 646, pages 123490.
Crossref
Crossref
Yongpeng Huang, Hui Tang, Dongxin Liu, Yanli Liu, Xiangyan Meng, Bo Chen & Zhiyun Zou. (2023) Cyclosporine A-loaded chitosan extra-fine particles for deep pulmonary drug delivery: In vitro and in vivo evaluation. Journal of Controlled Release 362, pages 243-256.
Crossref
Crossref
Arezoo Saberi, Maryam Kouhjani, Davood Yari, Afsaneh Jahani, Kofi Asare-Addo, Hossein Kamali & Ali Nokhodchi. (2023) Development, recent advances, and updates in binary, ternary co-amorphous systems, and ternary solid dispersions. Journal of Drug Delivery Science and Technology 86, pages 104746.
Crossref
Crossref
David Schütz, Annika Timmerhaus & Holger Grohganz. (2023) Wet granulation of co-amorphous indomethacin systems. International Journal of Pharmaceutics 644, pages 123318.
Crossref
Crossref
Zhiren Zou, Qiang Huang, Xiaobo Li, Xianzhi Liu, Lina Yin, Yunjie Zhao, Guang Liang & Wenqi Wu. (2023) Dissolution changes in drug-amino acid/biotin co-amorphous systems: Decreased/increased dissolution during storage without recrystallization. European Journal of Pharmaceutical Sciences 188, pages 106526.
Crossref
Crossref
Yuehua Deng, Shiyuan Liu, Yanbin Jiang, Inês C. B. Martins & Thomas Rades. (2023) Recent Advances in Co-Former Screening and Formation Prediction of Multicomponent Solid Forms of Low Molecular Weight Drugs. Pharmaceutics 15:9, pages 2174.
Crossref
Crossref
Arif Budiman, Eli Lailasari, Neng Vera Nurani, Ellen Nathania Yunita, Gracia Anastasya, Rizqa Nurul Aulia, Ira Novianty Lestari, Laila Subra & Diah Lia Aulifa. (2023) Ternary Solid Dispersions: A Review of the Preparation, Characterization, Mechanism of Drug Release, and Physical Stability. Pharmaceutics 15:8, pages 2116.
Crossref
Crossref
Katarzyna Trzeciak, Ewelina Wielgus, Sławomir Kaźmierski, Tomasz Pawlak & Marek J. Potrzebowski. (2023) Amorphization of Ethenzamide and Ethenzamide Cocrystals—A Case Study of Single and Binary Systems Forming Low-Melting Eutectic Phases Loaded on/in Silica Gel. Pharmaceutics 15:4, pages 1234.
Crossref
Crossref
Joana F. C. Silva, Mário T. S. Rosado, Teresa M. R. Maria, Pedro S. Pereira Silva, Manuela Ramos Silva & M. Ermelinda S. Eusébio. (2023) Introduction to Pharmaceutical Co-amorphous Systems Using a Green Co-milling Technique. Journal of Chemical Education 100:4, pages 1627-1632.
Crossref
Crossref
Yuta Hatanaka, Hiromasa Uchiyama, Shingo Furukawa, Mai Takase, Shinya Yamanaka, Kazunori Kadota & Yuichi Tozuka. (2023) Effect of Solubility Improvement <i>via</i> Formation of an Amorphous Composite of Indomethacin and Sulindac on Membrane Permeability. Chemical and Pharmaceutical Bulletin 71:3, pages 257-261.
Crossref
Crossref
Dandan Hu, Xin Chen, Duanxiu Li, Hailu Zhang, Yanwen Duan & Yong Huang. (2023) Tranilast-matrine co-amorphous system: Strong intermolecular interactions, improved solubility, and physiochemical stability. International Journal of Pharmaceutics 635, pages 122707.
Crossref
Crossref
Jiawei Han, Chuchu Zhang, Yanpei Zhang, Xiaoqian Liu & Jue Wang. (2023) Mechanistic insight into gel formation of co-amorphous resveratrol and piperine during dissolution process. International Journal of Pharmaceutics 634, pages 122644.
Crossref
Crossref
Hao Wu, Jia Ma, Shuaiqi Qian, Wenhao Jiang, Yuxi Liu, Jingjuan Li, Zhongcheng Ke & Kai Feng. (2023) Co-amorphization of posaconazole using citric acid as an acidifier and a co-former for solubility improvement. Journal of Drug Delivery Science and Technology 80, pages 104136.
Crossref
Crossref
Weili Heng, Yutong Song, Minqian Luo, Enshi Hu, Yuanfeng Wei, Yuan Gao, Zunting Pang, Jianjun Zhang & Shuai Qian. (2023) Mechanistic insights into the crystallization of coamorphous drug systems. Journal of Controlled Release 354, pages 489-502.
Crossref
Crossref
Jiawei Han, Yuanfeng Wei, Luyuan Li, Yutong Song, Zunting Pang, Shuai Qian, Jianjun Zhang, Yuan Gao & Weili Heng. (2023) Gelation Elimination and Crystallization Inhibition by Co-Amorphous Strategy for Amorphous Curcumin. Journal of Pharmaceutical Sciences 112:1, pages 182-194.
Crossref
Crossref
Shohei Aikawa, Hironori Tanaka, Hiroshi Ueda, Masato Maruyama & Kazutaka Higaki. (2022) Formation of a Stable Co-Amorphous System for a Brick Dust Molecule by Utilizing Sodium Taurocholate with High Glass Transition Temperature. Pharmaceutics 15:1, pages 84.
Crossref
Crossref
Nuno F. da Costa, Inês A. Santos, Ana I. Fernandes & João F. Pinto. (2022) Sulfonic Acid Derivatives in the Production of Stable Co-Amorphous Systems for Solubility Enhancement. Journal of Pharmaceutical Sciences 111:12, pages 3327-3339.
Crossref
Crossref
Nuno F. da Costa, Raquel F. Azevedo, João A. Lopes, Ana I. Fernandes & João F. Pinto. (2022) In Situ Co-Amorphization of Olanzapine in the Matrix and on the Coat of Pellets. Pharmaceutics 14:12, pages 2587.
Crossref
Crossref
Binyi Wang, Xiaolin Wang, Yunjing Zhu, Tian Yin, Jingxin Gou, Yanjiao Wang, Haibing He, Yu Zhang & Xing Tang. (2022) Characterization of nimodipine amorphous nanopowder prepared by quenching cooling combined with wet milling and spray drying. International Journal of Pharmaceutics 628, pages 122332.
Crossref
Crossref
Luz María Martínez, Jorge Cruz-Angeles, Mónica Vázquez-Dávila, Eduardo Martínez, Paulina Cabada, Columba Navarrete-Bernal & Flor Cortez. (2022) Mechanical Activation by Ball Milling as a Strategy to Prepare Highly Soluble Pharmaceutical Formulations in the Form of Co-Amorphous, Co-Crystals, or Polymorphs. Pharmaceutics 14:10, pages 2003.
Crossref
Crossref
Jiawei Han, Luyuan Li, Qian Yu, Daoyi Zheng, Yutong Song, Jianjun Zhang, Yuan Gao, Weili Heng, Shuai Qian & Zunting Pang. (2022) Self-gelation involved in the transformation of resveratrol and piperine from a co-amorphous system into a co-crystal system. CrystEngComm 24:32, pages 5733-5747.
Crossref
Crossref
Weili Heng, Xiaoshuang He, Yutong Song, Jiawei Han, Zunting Pang, Shuai Qian, Jianjun Zhang, Yuan Gao & Yuanfeng Wei. (2022) Insights into Cocrystallization and Coamorphization Engineering Techniques in the Delivery of Traditional Chinese Medicine: Formation Mechanism, Solid-State Characterization, and Improved Pharmaceutical Properties. Crystal Growth & Design 22:8, pages 5110-5134.
Crossref
Crossref
Luke I. ChambersOsama M. Musa & Jonathan W. Steed. (2022) Prediction and Preparation of Coamorphous Phases of a Bislactam. Molecular Pharmaceutics 19:7, pages 2651-2661.
Crossref
Crossref
Li Ming Lim, Jin-Won Park & Kunn Hadinoto. (2022) Benchmarking the Solubility Enhancement and Storage Stability of Amorphous Drug–Polyelectrolyte Nanoplex against Co-Amorphous Formulation of the Same Drug. Pharmaceutics 14:5, pages 979.
Crossref
Crossref
Hiroshi Ueda, Yuya Hirakawa, Tetsuya Miyano, Masaaki Imono, Jun Yee Tse, Hiromasa Uchiyama, Yuichi Tozuka & Kazunori Kadota. (2022) Design of a Stable Coamorphous System Using Lactose as an Antiplasticizing Agent for Diphenhydramine Hydrochloride with a Low Glass Transition Temperature. Molecular Pharmaceutics 19:4, pages 1209-1218.
Crossref
Crossref
Jingwen Liu, EnTe Hwu, Jacob Bannow, Holger Grohganz & Thomas Rades. (2022) Impact of Molecular Surface Diffusion on the Physical Stability of Co-Amorphous Systems. Molecular Pharmaceutics 19:4, pages 1183-1190.
Crossref
Crossref
Maria Terezinha França, Tatyane Martins Marcos, Paulo F.A. Costa, Giovana Carolina Bazzo, Rafael Nicolay Pereira, Adriana P. Gerola & Hellen Karine Stulzer. (2022) Eutectic mixture and amorphous solid dispersion: Two different supersaturating drug delivery system strategies to improve griseofulvin release using saccharin. International Journal of Pharmaceutics 615, pages 121498.
Crossref
Crossref
Jiawei Han, Luyuan Li, Zunting Pang, Meiling Su, Xiaoshuang He, Shuai Qian, Jianjun Zhang, Yuan Gao & Yuanfeng Wei. (2022) Mechanistic insight into gel-induced aggregation of amorphous curcumin during dissolution process. European Journal of Pharmaceutical Sciences 170, pages 106083.
Crossref
Crossref
Qin Shi, Fang Li, Stacy Yeh, Sakib M. Moinuddin, Junbo Xin, Jia Xu, Hao Chen & Bai Ling. (2021) Recent Advances in Enhancement of Dissolution and Supersaturation of Poorly Water-Soluble Drug in Amorphous Pharmaceutical Solids: A Review. AAPS PharmSciTech 23:1.
Crossref
Crossref
Yogesh Sutar, Tejabhiram Yadavalli, Sagar Kumar Paul, Sudipta Mallick, Raghuram Koganti, Harsh Chauhan, Abhijit A. Date & Deepak Shukla. (2021) BX795-Organic Acid Coevaporates: Evaluation of Solid-State Characteristics, In Vitro Cytocompatibility and In Vitro Activity against HSV-1 and HSV-2. Pharmaceutics 13:11, pages 1920.
Crossref
Crossref
Jiawei Han, Luyuan Li, Meiling Su, Weili Heng, Yuanfeng Wei, Yuan Gao & Shuai Qian. (2021) Deaggregation and Crystallization Inhibition by Small Amount of Polymer Addition for a Co-Amorphous Curcumin-Magnolol System. Pharmaceutics 13:10, pages 1725.
Crossref
Crossref
Olivier Tramis, Akiho Fujioka, Hiroyuki Imanaka, Naoyuki Ishida & Koreyoshi Imamura. (2021) Foaming characteristics of sugar- and polyvinylpyrrolidone-alcohol solutions during vacuum foam drying: A rheological approach. Colloids and Surfaces A: Physicochemical and Engineering Aspects 627, pages 127174.
Crossref
Crossref
Wen Li, Jiaqi Song, Jianfeng Li, Mo Li, Baocheng Tian, Zhonggui He, Xiaohong Liu & Qiang Fu. (2021) Co-amorphization of atorvastatin by lisinopril as a co-former for solubility improvement. International Journal of Pharmaceutics 607, pages 120971.
Crossref
Crossref
Ya-Wei Li, Hong-Mei Zhang, Bai-Ji Cui, Cheng-Yi Hao, He-Yun Zhu, Jiao Guan, Dan Wang, Ying Jin, Bo Feng, Jian-Hui Cai, Xian-Rong Qi & Nian-Qiu Shi. (2021) “Felodipine-indomethacin” co-amorphous supersaturating drug delivery systems: “Spring-parachute” process, stability, in vivo bioavailability, and underlying molecular mechanisms. European Journal of Pharmaceutics and Biopharmaceutics 166, pages 111-125.
Crossref
Crossref
Jingwen Liu, Thomas Rades & Holger Grohganz. (2021) The influence of moisture on the storage stability of co-amorphous systems. International Journal of Pharmaceutics 605, pages 120802.
Crossref
Crossref
Yanping Huang, Qin Yu, Zhongjian Chen, Wei Wu, Quangang Zhu & Yi Lu. (2021) In vitro and in vivo correlation for lipid-based formulations: Current status and future perspectives. Acta Pharmaceutica Sinica B 11:8, pages 2469-2487.
Crossref
Crossref
Jingwen Liu, Holger Grohganz, Korbinian Löbmann, Thomas Rades & Nele-Johanna Hempel. (2021) Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies. Pharmaceutics 13:3, pages 389.
Crossref
Crossref
Ridhima Singh, Vikram Joshi, Nitin Mehetre & Abhay T Sangamwar. (2021) Insights into co-amorphous systems in therapeutic drug delivery. Therapeutic Delivery 12:3, pages 245-265.
Crossref
Crossref
Marcin Skotnicki, Barbara Jadach, Agnieszka Skotnicka, Bartłomiej Milanowski, Lidia Tajber, Marek Pyda & Jacek Kujawski. (2021) Physicochemical Characterization of a Co-Amorphous Atorvastatin-Irbesartan System with a Potential Application in Fixed-Dose Combination Therapy. Pharmaceutics 13:1, pages 118.
Crossref
Crossref